Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Structure Activity Relationships and Biological Insights into PSMA 617 and Its Derivatives with Modified Lipophilic Linker Regions

Title: Structure Activity Relationships and Biological Insights into PSMA 617 and Its Derivatives with Modified Lipophilic Linker Regions
Authors: Schäfer, M.; Bauder Wüst, U.; Roscher, M.; Motlov , L.; Kutilov , Z.; Remde, Y.; Klika, K.D.; Graf, J.; Barinka, C; Benesov Schäfer, M.
Source: ACS Omega 10 2025 , p. 7077 7090
Publication Year: 2025
Collection: Helmholtz Zentrum Berlin (HZB): Publications
Subject Terms: Ligands; Tumors
Description: PSMA 617 is recognized as a benchmark ligand for prostate specific membrane antigen PSMA owing to its broad utilization in prostate cancer PCa targeted radionuclide therapy. In this study, the structure activity relationships SAR of PSMA 617 and two novel analogs featuring modified linkers were investigated. In compounds P17 and P18, the 2 naphthyl l Ala moiety was replaced with a less lipophilic 3 styryl l Ala moiety while the cyclohexyl ring in P18 was replaced with a phenyl group. The first ever crystal structure of the PSMA PSMA 617 complex reported here revealed a folded conformation of the PSMA 617 linker while for the PSMA P17 and PSMA P18 complexes, the extended orientations of the linkers revealed linker flexibility within the PSMA cavity, a change in binding that can be exploited for the structure guided design of PSMA targeting agents. Despite structural differences from PSMA 617, the analogs maintained high PSMA inhibition potency, cellular binding, and internalization. In vivo biodistribution studies revealed comparable tumor uptake across all three compounds with P18 displaying higher spleen accumulation, likely due to phenyl ring lipophilicity. These SAR findings provide a strategic framework for the rational design of PSMA ligands, paving the way for the development of next generation theranostic agents for PCa
Document Type: article in journal/newspaper
Language: unknown
Availability: https://www.helmholtz-berlin.de/pubbin/oai_publication?VT=1&ID=114796
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.54F807B4
Database: BASE